NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTCHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
NMTC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $9.83M
- EPS (TTM)
- -$0.99
- Dividend yield
- None
- 52-week range
- 0.962 – 6.42
- Day range
- 1.07 – 1.12
- Volume / Avg
- 291.51K / 339.60K
- Beta
- —
- Shares outstanding
- 9.11M
52-week range
NMTC stock today
NeuroOne Medical Technologies (NMTC) closed at $1.08 on Oct 8, down 2.70% (-$0.03), versus the S&P 500's 0.47% decline. At this level, NMTC sits near the bottom of its 52-week range of $0.962 to $6.42: 83.2% below the high and 12.3% above the low. NMTC is down 76.3% year to date, underperforming the S&P 500 (+13.5%). Over the past 12 months, the stock has lost 82.7%.
NeuroOne Medical Technologies has posted a net loss over the last twelve months (EPS of -$0.99), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About NeuroOne Medical Technologies
Company profileNeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. David A. Rosa M.D.
- Headquarters
- Eden Prairie, MN
- Employees
- 18
- Website
- nmtc1.com
Analyst forecast
ForecastConsensus (3 analysts)
strong_buy
Avg. price target
$7.27+573.15%
- Strong buy 1
- Buy 2
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
NMTC news
All NMTC newsNeuroOne Medical Technologies peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AEMDAethlon Medical Inc. | 6.01 | -0.99% | $9.64M | vs NMTC |
| TNONTenon Medical Inc. | 3.44 | -1.71% | $9.25M | vs NMTC |
| BMRABiomerica Inc. | 1.89 | -0.53% | $8.69M | vs NMTC |
| CTSOCytosorbents Corporation | 3.73 | -3.62% | $11.75M | vs NMTC |
| CODXCo-Diagnostics Inc. | 1.09 | -2.68% | $7.61M | vs NMTC |
| PLSMPulsenmore Ltd. | 1.92 | +0.73% | $12.49M | vs NMTC |
| WOKWORK Medical Technology Group LTD Class A | 1.52 | -1.94% | $6.79M | vs NMTC |
| VNRXVolitionRX Limited | 0.2194 | -2.92% | $6.60M | vs NMTC |
Indexes, lists and sector
Appears in lists
NeuroOne Medical Technologies stock FAQ
What is NeuroOne Medical Technologies's stock price today?
NMTC last traded at $1.08 as of Oct 8, 4:00 PM EDT, down 2.70% on the day. Prices are delayed at least 15 minutes.
Does NeuroOne Medical Technologies pay a dividend?
No. NeuroOne Medical Technologies does not currently pay a regular cash dividend.
Who is NeuroOne Medical Technologies's CEO?
Mr. David A. Rosa M.D. is the chief executive officer of NeuroOne Medical Technologies Corporation, which has about 18 employees.
Has NMTC ever split its stock?
Yes. The most recent NMTC stock split was a 1-for-6 split on Apr 16, 2026, one of 2 splits on record.
What is the NMTC 52-week high?
The 52-week high for NMTC is $6.42 and the 52-week low is $0.962. The stock is currently 83.2% below its high.